PMID

Data

Article Title

Organization

Discovery of potential novel TRPC5 inhibitors by virtual screening and bioassay.

Chinese Academy of Sciences

Biological Effects of Modifications of the Englerin A Glycolate.

National Cancer Institute

Discovery of pyrroledione analogs as potent transient receptor potential canonical channel 5 inhibitors.

China Pharmaceutical University

Synthesis of AC1903 analogs as potent transient receptor potential canonical channel 4/5 inhibitors and biological evaluation.

Chinese Academy of Sciences

Potential Treatment for Neuropsychiatry Disorders with TRPC5 Modulators.

Therachem Research Medilab (India)

Discovery of a Potent and Selective TRPC5 Inhibitor, Efficacious in a Focal Segmental Glomerulosclerosis Model.

Goldfinch Bio

Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases.

University of Nebraska Medical Center

Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903.

University of Nebraska Medical Center

Discovery of Pyrrolidine Sulfonamides as Selective and Orally Bioavailable Antagonists of Transient Receptor Potential Vanilloid-4 (TRPV4).

TBA

Thieno- and furo[2,3-d]pyrimidine-2,4[1H,3H]-dione derivatives

Hydra Biosciences